{"DataElement":{"publicId":"6060045","version":"1","preferredName":"Enneking Musculoskeletal Tumor Society Staging System Stage","preferredDefinition":"Text term used to describe the stage of the musculoskeletal sarcoma, using the Enneking staging system approved by the Musculoskeletal Tumor Society (MSTS).","longName":"enneking_msts_stage","context":"GDC","contextVersion":"1","DataElementConcept":{"publicId":"6059608","version":"1","preferredName":"Enneking Staging System Musculoskeletal System Sarcoma","preferredDefinition":"A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis._The system of muscles, tendons, ligaments, bones, joints and associated tissues that move the body and maintain its form._A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","longName":"6003931v1.0:6059606v1.0","context":"GDC","contextVersion":"1","ObjectClass":{"publicId":"6003931","version":"1","preferredName":"Enneking Staging System","preferredDefinition":"A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis.","longName":"C140258","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enneking Staging System","conceptCode":"C140258","definition":"A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6E481C-8895-18E2-E053-F662850AFB90","latestVersionIndicator":"Yes","beginDate":"2017-10-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6059606","version":"1","preferredName":"Musculoskeletal System Sarcoma","preferredDefinition":"The system of muscles, tendons, ligaments, bones, joints and associated tissues that move the body and maintain its form.:A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","longName":"C12754:C9118","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Musculoskeletal System","conceptCode":"C12754","definition":"The system of muscles, tendons, ligaments, bones, joints and associated tissues that move the body and maintain its form.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"641A0A1E-DE17-4D0D-E053-F662850AE35C","latestVersionIndicator":"Yes","beginDate":"2018-02-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-01","modifiedBy":"ONEDATA","dateModified":"2018-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"641A0A1E-DE28-4D0D-E053-F662850AE35C","latestVersionIndicator":"Yes","beginDate":"2018-02-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-01","modifiedBy":"COOPERM","dateModified":"2020-08-17","changeDescription":"Created for Q12018 dictionary update request 1/30/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6060039","version":"1","preferredName":"Enneking Staging System MSTS Stage","preferredDefinition":"A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6060039v1.0","context":"GDC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6479233B-1A0F-3ADC-E053-F662850AF601","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6479233B-1A19-3ADC-E053-F662850AF601","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Enneking Stage III","ValueMeaning":{"publicId":"6060040","version":"1","preferredName":"Enneking Stage III","longName":"6060040","preferredDefinition":"A stage for malignant musculoskeletal tumors characterized by any grade, any site, and regional or distant metastasis (M1).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enneking Stage III","conceptCode":"C146705","definition":"A stage for malignant musculoskeletal tumors characterized by any grade, any site, and regional or distant metastasis (M1).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6479233B-1A25-3ADC-E053-F662850AF601","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6479233B-1A3E-3ADC-E053-F662850AF601","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"Stage IIB","valueDescription":"Enneking Stage IIB","ValueMeaning":{"publicId":"6060041","version":"1","preferredName":"Enneking Stage IIB","longName":"6060041","preferredDefinition":"A stage for malignant musculoskeletal tumors characterized by high grade (G2), intracomparmental site (T2), and no metastasis (M0).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enneking Stage IIB","conceptCode":"C146704","definition":"A stage for malignant musculoskeletal tumors characterized by high grade (G2), intracomparmental site (T2), and no metastasis (M0).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6479233B-1A4A-3ADC-E053-F662850AF601","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6479233B-1A63-3ADC-E053-F662850AF601","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"Stage IIA","valueDescription":"Enneking Stage IIA","ValueMeaning":{"publicId":"6060042","version":"1","preferredName":"Enneking Stage IIA","longName":"6060042","preferredDefinition":"A stage for malignant musculoskeletal tumors characterized by high grade (G2), intracomparmental site (T1), and no metastasis (M0).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enneking Stage IIA","conceptCode":"C146703","definition":"A stage for malignant musculoskeletal tumors characterized by high grade (G2), intracomparmental site (T1), and no metastasis (M0).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6479233B-1A6F-3ADC-E053-F662850AF601","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6479233B-1A88-3ADC-E053-F662850AF601","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"Stage IB","valueDescription":"Enneking Stage IB","ValueMeaning":{"publicId":"6060043","version":"1","preferredName":"Enneking Stage IB","longName":"6060043","preferredDefinition":"A stage for malignant musculoskeletal tumors characterized by low grade (G1), extracomparmental site (T2), and no metastasis (M0).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enneking Stage IB","conceptCode":"C146702","definition":"A stage for malignant musculoskeletal tumors characterized by low grade (G1), extracomparmental site (T2), and no metastasis (M0).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6479233B-1A94-3ADC-E053-F662850AF601","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6479233B-1AAD-3ADC-E053-F662850AF601","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"},{"value":"Stage IA","valueDescription":"Enneking Stage IA","ValueMeaning":{"publicId":"6060044","version":"1","preferredName":"Enneking Stage IA","longName":"6060044","preferredDefinition":"A stage for malignant musculoskeletal tumors characterized by low grade (G1), intracomparmental site (T1), and no metastasis (M0).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enneking Stage IA","conceptCode":"C146701","definition":"A stage for malignant musculoskeletal tumors characterized by low grade (G1), intracomparmental site (T1), and no metastasis (M0).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6479233B-1AB9-3ADC-E053-F662850AF601","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6479233B-1AD2-3ADC-E053-F662850AF601","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6003947","version":"1","preferredName":"Enneking Staging System Stage","preferredDefinition":"A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C140258:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enneking Staging System","conceptCode":"C140258","definition":"A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B7001D2-0CA5-0C95-E053-F662850AE118","latestVersionIndicator":"Yes","beginDate":"2017-10-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Enneking SSS/MSTS: Enneking Surgical Staging System adopted by the Musculoskeletal Tumor Society, Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. 1980","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6479233B-19F7-3ADC-E053-F662850AF601","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"COLBERTM","dateModified":"2020-08-21","changeDescription":"Created for Q12018 dictionary update request 1/30/18 mc  Verified this is in use by GDC, OK to release. MRC 8/21/20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"10000695","version":"1","longName":"Diagnosis","context":"GDC"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Enneking/MSTS staging system;","type":"Preferred Question Text","description":"Enneking/MSTS staging system; Stage","url":null,"context":"GDC"}],"origin":"Enneking SSS/MSTS: Enneking Surgical Staging System adopted by the Musculoskeletal Tumor Society, Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. 1980","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64793058-C0C1-4ABE-E053-F662850A1960","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"COLBERTM","dateModified":"2020-08-21","changeDescription":"Created for Q12018 dictionary update request 1/30/18 mc  Verified this is in use by GDC, ok to release. MRC 8/21/20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}